Aneuvo reported raising $22 Million in an initial SEC Form D filing, from an offering of $200,000
Round Type
Series C
Description
Aneuvo raised $22 million in a Series C funding round to further develop its innovative technologies. This funding will support the company's growth and expansion initiatives. The round was led by prominent investors in the tech industry. Aneuvo aims to leverage these funds to enhance its product offerings.
Who else raised in Healthcare and Health Care around the same time
Companies in the same sectors as Aneuvo that raised within 45 days of this round, from Fundz verified event records.
- MiRTLE Medical raised $590K on June 1, 2026.
- Tempest Therapeutics raised $4.1M on May 29, 2026.
- Spine BioPharma raised $385K (Series B) on May 22, 2026.
- AIM ImmunoTech raised $2.4M (Post-IPO Equity) on May 20, 2026.
- IRulya Therapeutics Inc. raised $115M on May 18, 2026.
- Cagent Vascular raised $41M (Series D) on May 18, 2026.
Who to call at Aneuvo, and when
A new round usually means Aneuvo is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Aneuvo raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Aneuvo, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Aneuvo. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Aneuvo raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Aneuvo raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.